Personalizing Your Prostate Cancer Treatment Through Genomics

Genetics vs Genomics

The Oncotype DX Genomic Prostate Score® test is based on genomic science. While genomics and genetics may sound similar, and are indeed related, they focus on different information.

Genetics can help to tell you your risk for getting cancer and determine if specific treatments will be effective. Genomics can help once you have cancer to guide your course of care.


Genetics

Genomics 

Study of inherited traits, such as hair or eye color, that are passed from one generation to the next through genes1. Study of the activity and interaction of certain genes in the body, including their role in certain diseases.1
Your risk for certain cancers can be inherited, or passed through your genes.1 Once you have cancer, the activity and interaction of certain genes in your tumor tissue influences the behavior of your tumor, including how likely it is to grow and spread.1
The test for the BRCA1 and BRCA2 genes is a genetic test that can help predict your risk for getting prostate cancer or your responsiveness to certain treatments.3 The Oncotype DX Genomic Prostate Score® test is a genomic test that can help to predict the aggressiveness of your tumor and can help with choosing appropriate treatment options.
Once you know your genetic risk for cancer, you can take steps to lower that risk, such as making lifestyle changes. Once you have the personalized information from your Oncotype DX Genomic Prostate Score test, you and your doctor can decide what kind of treatment (if any) you might need.

Download the ZERO Genomic Testing 101 Guide >>

 

References

1. National Human Genome Research Institute. 2018.

2. National Cancer Institute

3. Nyberg et al. Eur Urol. 2020